Quantcast
Last updated on April 17, 2014 at 11:32 EDT

Latest pharmaceutical industry Stories

2014-04-10 08:29:24

DUBLIN, Ireland, April 10, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/g7zq72/pharmaceutical) has announced the addition of the "Pharmaceutical Regulatory Affairs in Africa - Including South Africa (Seminar, London) - 28th & 29th April 2014" [http://www.researchandmarkets.com/research/g7zq72/pharmaceutical ] conference to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The...

2014-04-10 08:29:11

DUBLIN, April 10, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/fcfbhm/pharmaceutical) has announced the addition of the "Pharmaceutical Regulatory Affairs in the Middle East - Bahrain, Egypt, Iran Iraq Israel, Jordan, Kuwait, Lebanon, Libya, Oman Palestine, Qatar, Saudi Arabia, Sudan Syria, UAE, Yemen (Seminar, London)" [http://www.researchandmarkets.com/research/fcfbhm/pharmaceutical ] conference to their offering. (Logo:...

2014-04-10 08:29:04

DUBLIN, April 10, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/t45c8d/fda_approval) has announced the addition of the "FDA Approval Process for Medical Devices - Updated Programme Includes all the Current FDA Guidelines (Seminar, London)" [http://www.researchandmarkets.com/research/t45c8d/fda_approval ]conference to their offering. (Photo: http://photos.prnewswire.com/prnh/20130307/600769 ) The FDA Approval Process...

2014-04-09 23:26:42

For the April 4 issue of Atlantic Information Services’s Drug Benefit News, an Avalere consultant explained why PBMs and commercial payers are indirectly losing money on the 340B Drug Pricing Program, even though drug companies are the primary stakeholders. Washington, DC (PRWEB) April 09, 2014 A new report from a coalition of stakeholders suggests that a considerable portion of hospitals enrolled in the 340B Drug Pricing Program provides a negligible amount of free or reduced-price...

2014-04-09 23:02:58

Comprehensive research report “OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017” worked out by GlobalData is now available at MarketPublishers.com. According to the study, by 2017-end, pancreatic cancer sales are projected to rise to USD 1.63 billion in the US and 5EU. London, UK (PRWEB) April 09, 2014 The pancreatic cancer market value in the US and 5EU (the six major markets, or 6MM) in 2012 was USD 529 million. Just over 50% of pancreatic cancer...

2014-04-09 16:26:03

WASHINGTON, April 9, 2014 /PRNewswire-USNewswire/ -- Congressman Chaka Fattah (D-PA), a Senior Member on the House Appropriations Committee and architect of the Fattah Neuroscience Initiative, released the following statement on the announcement that the University of California-San Francisco will launch a new online brain research registry: "I commend UCSF for launching this innovative new tool that has the potential to transform the way clinical trials are conducted as we continue...

2014-04-09 16:25:46

PHILADELPHIA, April 9, 2014 /PRNewswire/ -- Greenphire, the leading provider of payment technology for the clinical trial industry, today announced the launch of a strategic partnership with ERT, a global leader in high-quality patient safety and efficacy endpoint data collection. The partnership will integrate Greenphire's ClinCard System with ERT's best-in-class electronic patient reported outcomes (ePRO) technology. "By incorporating our ClinCard technology with ERT's remote...

2014-04-09 16:25:20

DUBLIN, April 9, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/k3xnm6/molecular) has announced the addition of the "Molecular Diagnostics in Cancer Testing" [http://www.researchandmarkets.com/research/k3xnm6/molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and...

2014-04-09 12:31:33

DUBLIN, April 9, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/fkn6g5/vaccine_market_by) has announced the addition of the "Vaccine Market by Technology & Types, Various Classes & Indications - Global Forecasts To 2022" [http://www.researchandmarkets.com/research/fkn6g5/vaccine_market_by ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The global vaccine technology...

2014-04-09 12:30:41

SHANGHAI, April 9, 2014 /PRNewswire/ -- In China NPC & CPPCC 2014, encouragement of transportation for pharmacy from API manufacturers to formulation manufacturers, formulation export, speed up new drug application and reform of basic drug bidding have become hot topics again. (Photo: http://photos.prnasia.com/prnh/20140409/0861402219-a ) (Photo: http://photos.prnasia.com/prnh/20140409/0861402219-b ) Due to the success from 2 years of Pharma QbD, 4 years of Pharma Supply Chain, 4 years...